Literature DB >> 7564790

Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia.

G T Berry1, I Nissim, Z Lin, A T Mazur, J B Gibson, S Segal.   

Abstract

Despite restricted ingestion of lactose, patients with galactose-1-phosphate uridyltransferase deficiency have raised concentrations of galactose metabolites in blood and urine. Endogenous production of galactose may underlie this phenomenon. Using isotopically labelled galactose in a continuous intravenous infusion, we employed the steady-state flux method to calculate endogenous galactose production rate in three normal men and three patients with classic galactosaemia. We found that galactosaemic patients and normal subjects synthesise gram quantities of galactose per day. The rate of synthesis ranged from 0.53-1.05 mg/kg per h. Endogenous production of galactose may be an important factor in the pathogenesis of the complications of the brain and ovary, and could explain the persistent elevation of galactose metabolites in patients despite dietary restriction of galactose.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564790     DOI: 10.1016/s0140-6736(95)91745-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  48 in total

1.  Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group.

Authors:  J H Walter; J E Collins; J V Leonard
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

2.  Structure-activity analysis and cell-based optimization of human galactokinase inhibitors.

Authors:  Si Odejinmi; Rg Rascon; M Tang; H Vankayalapati; K Lai
Journal:  ACS Med Chem Lett       Date:  2011-09-08       Impact factor: 4.345

3.  Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia.

Authors:  Gerard T Berry; Louis J Elsas
Journal:  J Inherit Metab Dis       Date:  2010-11-30       Impact factor: 4.982

Review 4.  Innovative therapy for Classic Galactosemia - tale of two HTS.

Authors:  M Tang; S I Odejinmi; H Vankayalapati; K J Wierenga; K Lai
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

Review 5.  Galactosaemia: pathogenesis and treatment.

Authors:  J B Holton
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Komrower Lecture. Galactosaemia today: the enigma and the challenge.

Authors:  S Segal
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

7.  Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment.

Authors:  K P Coss; P P Doran; C Owoeye; M B Codd; N Hamid; P D Mayne; E Crushell; I Knerr; A A Monavari; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2012-07-03       Impact factor: 4.982

Review 8.  Applications of mass spectrometry in the study of inborn errors of metabolism.

Authors:  P T Clayton
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

Review 9.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

10.  Rigor of non-dairy galactose restriction in early childhood, measured by retrospective survey, does not associate with severity of five long-term outcomes quantified in 231 children and adults with classic galactosemia.

Authors:  Allison B Frederick; David J Cutler; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2017-07-10       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.